Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.48 AUD | +0.81% | +2.06% | -14.19% |
Mar. 05 | Australia shares inch lower as miners weigh; GDP data in focus | RE |
Feb. 28 | Australian Clinical Labs Falls 11% After Trimming Interim Dividend on Lower H1 FY24 EPS | MT |
Sales 2024 * | 683M 451M | Sales 2025 * | 711M 469M | Capitalization | 493M 325M |
---|---|---|---|---|---|
Net income 2024 * | 29M 19.12M | Net income 2025 * | 38M 25.05M | EV / Sales 2024 * | 0.78 x |
Net Debt 2024 * | 39.25M 25.88M | Net Debt 2025 * | 17.81M 11.74M | EV / Sales 2025 * | 0.72 x |
P/E ratio 2024 * |
17.3
x | P/E ratio 2025 * |
12.7
x | Employees | 5,115 |
Yield 2024 * |
3.49% | Yield 2025 * |
4.61% | Free-Float | 55.78% |
Latest transcript on Australian Clinical Labs Limited
1 day | +0.81% | ||
1 week | +2.06% | ||
Current month | +2.06% | ||
1 month | -4.62% | ||
3 months | -13.29% | ||
6 months | -5.70% | ||
Current year | -14.19% |
Managers | Title | Age | Since |
---|---|---|---|
Melinda McGrath
CEO | Chief Executive Officer | - | 14-12-31 |
James Davison
DFI | Director of Finance/CFO | - | 14-12-31 |
Tony Landgren
CTO | Chief Tech/Sci/R&D Officer | - | 08-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Alscher
CHM | Chairman | 56 | 14-12-31 |
Leanne Rowe
BRD | Director/Board Member | 67 | 21-04-27 |
Director/Board Member | - | 23-08-22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 2 M€ | -.--% | ||
0.01% | 7 M€ | -.--% | - | |
0.00% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 2.48 | +0.81% | 146 900 |
24-05-06 | 2.46 | +0.82% | 948,001 |
24-05-03 | 2.44 | +1.24% | 413,141 |
24-05-02 | 2.41 | -0.41% | 337,958 |
24-05-01 | 2.42 | -0.41% | 296,828 |
Delayed Quote Australian S.E., May 07, 2024 at 02:10 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.19% | 327M | |
+14.55% | 81.21B | |
-29.12% | 70.26B | |
+11.76% | 29.62B | |
-11.55% | 16.95B | |
-1.21% | 16.91B | |
-1.62% | 15.07B | |
-2.19% | 12.52B | |
-31.58% | 11.92B | |
-5.39% | 12.1B |
- Stock Market
- Equities
- ACL Stock